CAS 16271-33-3 | AMG131-005 : AMG-131
(World's Largest Pharmaceutical Supplier)

CAS 16271-33-3 is a synthetic cannabinoid that has been banned in many countries due to its high toxicity. It is structurally similar to other synthetic cannabinoids and belongs to the group of non-THC cannabinoids.

CAS 16271-33-3 was first synthesized in the late 2000s and has since become popular as a legal alternative to cannabis. However, it is important to note that this substance is not approved for human consumption and its safety has not been established.

The pharmacological effects of CAS 16271-33-3 are not well understood, but it is believed to act as a partial agonist at the cannabinoid receptors CB1 and CB2. Similar to other synthetic cannabinoids, CAS 16271-33-3 can produce a range of effects including euphoria, relaxation, and cognitive impairment.

In addition to its recreational use, CAS 16271-33-3 has also been reported to have medical applications. Preclinical studies have shown that it may have anti-inflammatory, analgesic, and anti-tumor properties. However, these findings need to be confirmed in human studies before any conclusions can be drawn.

The toxicity of CAS 16271-33-3 is a major concern, as it has been associated with several cases of overdose and death. The potency and toxicity of this substance are difficult to predict, and its use carries significant risks. Therefore, it is strongly recommended that individuals avoid using CAS 16271-33-3 or any other untested synthetic cannabinoids.